{"id":142219,"key":"Responses_to_Commentaries_on_“Ethics_as_if_Your_Life_Depended_on_It”","title":"Responses to Commentaries on “Ethics as if Your Life Depended on It”","latest":{"id":1266677,"timestamp":"2026-09-09T22:09:20Z"},"content_model":"wikitext","license":{"url":"https://www.appropedia.org/Appropedia:Copyrights","title":"CC-BY-SA-4.0"},"source":"{{FAST notice}}\n\n[[File:Ethics.png|thumb]]\n\n{{Publication data\n| type = Paper\n| cite-as = Pearce JM. Responses to Commentaries on “Ethics as if Your Life Depended on It”. ''Journal of Empirical Research on Human Research Ethics''. 2026;21(4):407-412. https://doi.org/10.1177/15562646261473069 https://journals.sagepub.com/doi/10.1177/15562646261453477 [https://www.academia.edu/170930773/Responses_to_Commentaries_on_Ethics_as_if_Your_Life_Depended_on_It_ OA Academia]\n| year = 2026\n| location = Canada\n}}\n\nResponses to Dr. Robert Steel and to Dr. Min-Fu Tsan.\n\nSteel's commentary raises valid concerns, but my model ultimately provides a more equitable and effective solution for addressing the ethical failures of the current system. By prioritizing autonomy, transparency, and urgency, my framework ensures that the voices of those most affected by fatal diseases are heard and respected. The evidence that I cite supporting adaptive trial designs, post-market surveillance, and enhanced consent processes demonstrates that the risks raised in Steel's commentary can be mitigated. Overall, the proposed new framework could reduce drug approval timelines by years, significantly accelerating access for patients with fatal diseases. While risks exist, evidence from COVID-19 trials and adaptive designs suggests that these can be managed effectively through transparency and post-market surveillance. For patients facing life-threatening conditions, the democratized ethics model offers hope and justice that the standard model often fails to deliver.\n\nOn the other hand, Tsan's defense of the status quo fails at three levels. Empirically, it denies IRB delays that the literature shows plainly exist. Conceptually, it misapplies therapeutic misconception to a normative argument about institutional authority. Ethically, it does not answer the central question: why should terminally ill, informed consenting adults be denied greater authority over risk when the cost of caution is often death? My commentary, while perhaps normatively bold, is empirically defensible. Tsan's response, in contrast, contains internal contradictions, ignores cited evidence, and substitutes assertion for engagement. As I clearly showed in the original commentary, IRB delays result in more human mortality than they protect. The current system is not logically defensible, and it is long past time that we fixed it.\n\nRead the main article: [[Ethics as if Your Life Depended on It]]\n\n{{Pearce publications notice}}\n\n== See also ==\n\n{{Pearce-death-ethics}}\n\n {{Pearce-OSmedical}}\n\n{{Page data\n| keywords = ethics, medical ethics, research ethics, IRB,\nHealth Sciences, Medical Sciences, Ethics, Applied Ethics,\nPublic Health\n| sdg = SDG03 Good health and well-being, SDG09 Industry innovation and infrastructure\n| published = 2026\n| organizations = Free Appropriate Sustainable Technology, Western\n| license = CC-BY-SA-4.0\n| language = en\n}}\n\n[[Category:Education]]\n[[Category:Medical]]\n[[Category:FAST Completed]]"}